Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04749459 · ClinicalTrials.gov registry record · NA

Sun Protection Factor (SPF) Determination of Two Sunscreen-Containing Lip Balms

A NA study of Sunscreening Agents, sponsored by GlaxoSmithKline.

Completed
Registry status
NA
Development phase
14
Enrollment target
1
Study location

NCT04749459 is a NA study of Sunscreening Agents that has completed, run by GlaxoSmithKline. The registered enrollment target is 14 participants, below the 80-participant average among 21 other Sunscreening Agents trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04749459, a NA study of Sunscreening Agents, has completed, sponsored by GlaxoSmithKline.

COMPLETED
Registry status
NA
Development phase
14 participants
Enrollment target
1
Study location

Study Summary

The aim of this study is to determine the SPF of two test materials ChapStick Moisturizer, Classic Flavor and ChapStick Moisturizer, Strawberry Flavor using the methodology described in the International Standard Test Method. This static methodology also meets the requirements of the Australia/New Zealand standard.

Conditions Studied

Interventions

  • DRUG ChapStick Moisturizer, Strawberry Flavor
  • DRUG ChapStick Moisturizer, Classic Flavor
  • DRUG ISO 24444:2010 P2 Standard Reference Sunscreen

Study Locations (1)

New Jersey

  • GSK Investigational Site - Fairfield

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2021-03-03
Est. Completion 2021-03-31
Phase NA

Sponsor

GlaxoSmithKline

1,345 total trials

What the Registry Record Tells You About NCT04749459

The ClinicalTrials.gov registry entry for NCT04749459 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 80-participant average among 21 other Sunscreening Agents trials with a reported enrollment target (82% lower). The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Sunscreening Agents appearing as the primary indexed condition, and to 3 interventions - of which ChapStick Moisturizer, Strawberry Flavor is the first listed.

NCT04749459 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT04749459 about?

NCT04749459 is a clinical study titled "Sun Protection Factor (SPF) Determination of Two Sunscreen-Containing Lip Balms". The aim of this study is to determine the SPF of two test materials ChapStick Moisturizer, Classic Flavor and ChapStick Moisturizer, Strawberry Flavor using the methodology described in the International Standard Test Method. This static methodology also meets the requirements of the Australia/New Z...

What is the current status of trial NCT04749459?

This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2021-03-03. Estimated completion is 2021-03-31.

What conditions does trial NCT04749459 study?

This clinical trial studies the following conditions: Sunscreening Agents.

What interventions are being tested in trial NCT04749459?

The interventions under investigation include: ChapStick Moisturizer, Strawberry Flavor (DRUG), ChapStick Moisturizer, Classic Flavor (DRUG), ISO 24444:2010 P2 Standard Reference Sunscreen (DRUG).

Who is sponsoring clinical trial NCT04749459?

This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04749459 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sunscreening Agents

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.